title: Bleeding avoidance in transcatheter aortic valve replacement: a call to ACTion?
authors.affiliation: Zena and Michael A. Wiener Cardiovascular Institute of the Icahn School of Medicine at Mount Sinai, New York, New York.
authors.forename: Matthew I
authors.initials: MI
authors.lastname: Tomey
authors.affiliation: Zena and Michael A. Wiener Cardiovascular Institute of the Icahn School of Medicine at Mount Sinai, New York, New York; Cardiovascular Research Foundation, New York, New York. Electronic address: roxana.mehran@mountsinai.org.
authors.forename: Roxana
authors.initials: R
authors.lastname: Mehran
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage*; D001024:Aortic Valve Stenosis / Q000628:therapy*; D001777:Blood Coagulation / Q000187:drug effects*; D006328:Cardiac Catheterization; D005260:Female; D005263:Femoral Artery; D019918:Heart Valve Prosthesis Implantation / Q000379:methods*; D006470:Hemorrhage / Q000517:prevention & control*; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D014914:Whole Blood Coagulation Time
chemical_list: D000925:Anticoagulants; D006493:Heparin
keywords: activated clotting time; bleeding; heparin; transcatheter aortic valve replacement